Evotec and Bristol-Myers Squibb expand iPSC collaboration
[caption id="attachment_9277" align="alignleft" width="1079"] Press Release[/caption]
- ADDING CELL TYPES SUPPORTS DISCOVERY OF DISEASE-MODIFYING THERAPIES FOR NEURODEGENERATIVE DISEASES AND TRIGGERS US$ 6 M PAYMENT TO EVOTEC